Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized budesonide for prevention of extubation failure in neonates
IRCT20201222049802N6Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of budesonide in respiratory distress syndrome (RDS) (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoint: Extubation success. Started Jun 2025; status: completed.
02
Drugs
budesonide
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT20201222049802N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201222049802N6.